DCN Diagnostics
PrivateLast Round
Growth Equity
Nov 3, 2020
Company Overview
DCN Diagnostics is a biotechnology company that provides contract development, manufacturing, and clinical research services for in vitro diagnostic (IVD) products.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Compliance
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DCN Diagnostics Comparables
Compare DCN Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abingdon Health Plc | 91% | |
| True Diagnostics, Inc. | 83% | |
| Fortis Life Sciences | 82% |
DCN Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Nov 3, 2020 |
Key People
Founding team and executive leadership
DCN Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Martis Capital Management | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 31, 2026
Monthly visitors increased 62% MoM, reaching 12.7K.
- Jun 1, 2025
Monthly visitors increased 91% MoM, reaching 10.1K.
DCN Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DCN Diagnostics's valuation, stock price, and market status.
Is DCN Diagnostics a public or private company?
DCN Diagnostics is a private company.
What is the current stock price of DCN Diagnostics?
DCN Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is DCN Diagnostics worth (valuation)?
Valuation information for DCN Diagnostics is not publicly available.
Can I buy DCN Diagnostics stock?
DCN Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was DCN Diagnostics's last funding round?
DCN Diagnostics's most recent funding round was Growth Equity on November 3, 2020.
Who are the main investors in DCN Diagnostics?
Key investors in DCN Diagnostics include Martis Capital Management.
Will DCN Diagnostics IPO soon?
No public IPO plans have been announced for DCN Diagnostics.
How can I track DCN Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DCN Diagnostics's secondary market activity and sign up for updates.